关注
Jonathan Javitch
Jonathan Javitch
未知所在单位机构
在 cumc.columbia.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective …
JA Javitch, RJ D'Amato, SM Strittmatter, SH Snyder
Proceedings of the National Academy of Sciences 82 (7), 2173-2177, 1985
15921985
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist
EYT Chien, W Liu, Q Zhao, V Katritch, G Won Han, MA Hanson, L Shi, ...
Science 330 (6007), 1091-1095, 2010
13462010
Functional selectivity and classical concepts of quantitative pharmacology
JD Urban, WP Clarke, M Von Zastrow, DE Nichols, B Kobilka, H Weinstein, ...
Journal of Pharmacology and Experimental Therapeutics 320 (1), 1-13, 2007
13142007
Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6
JA Ballesteros, AD Jensen, G Liapakis, SGF Rasmussen, L Shi, U Gether, ...
Journal of Biological Chemistry 276 (31), 29171-29177, 2001
8202001
Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors
JA Ballesteros, L Shi, JA Javitch
Molecular Pharmacology 60 (1), 1-19, 2001
5392001
β2 adrenergic receptor activation: Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch
L Shi, G Liapakis, R Xu, F Guarnieri, JA Ballesteros, JA Javitch
Journal of Biological Chemistry 277 (43), 40989-40996, 2002
5002002
Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism
C Saunders, JV Ferrer, L Shi, J Chen, G Merrill, ME Lamb, ...
Proceedings of the National Academy of Sciences 97 (12), 6850-6855, 2000
4792000
Building a new conceptual framework for receptor heteromers
S Ferré, R Baler, M Bouvier, MG Caron, LA Devi, T Durroux, K Fuxe, ...
Nature chemical biology 5 (3), 131-134, 2009
4772009
Treatment resistant depression: a multi-scale, systems biology approach
H Akil, J Gordon, R Hen, J Javitch, H Mayberg, B McEwen, MJ Meaney, ...
Neuroscience & Biobehavioral Reviews 84, 272-288, 2018
4322018
The mechanism of a neurotransmitter: sodium symporter—inward release of Na+ and substrate is triggered by substrate in a second binding site
L Shi, M Quick, Y Zhao, H Weinstein, JA Javitch
Molecular cell 30 (6), 667-677, 2008
4282008
The binding sites for cocaine and dopamine in the dopamine transporter overlap
T Beuming, J Kniazeff, ML Bergmann, L Shi, L Gracia, K Raniszewska, ...
Nature neuroscience 11 (7), 780-789, 2008
4132008
The binding site of aminergic G protein–coupled receptors: the transmembrane segments and second extracellular loop
L Shi, JA Javitch
Annual review of pharmacology and toxicology 42 (1), 437-467, 2002
4012002
Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation
Y Han, IS Moreira, E Urizar, H Weinstein, JA Javitch
Nature chemical biology 5 (9), 688-695, 2009
4002009
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues
L Albizu, M Cottet, M Kralikova, S Stoev, R Seyer, I Brabet, T Roux, ...
Nature chemical biology 6 (8), 587-594, 2010
3872010
Discovery of β-arrestin–biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy
JA Allen, JM Yost, V Setola, X Chen, MF Sassano, M Chen, S Peterson, ...
Proceedings of the National Academy of Sciences 108 (45), 18488-18493, 2011
3822011
Amphetamine induces dopamine efflux through a dopamine transporter channel
KM Kahlig, F Binda, H Khoshbouei, RD Blakely, DG McMahon, JA Javitch, ...
Proceedings of the National Academy of Sciences 102 (9), 3495-3500, 2005
3812005
Dopamine D2 receptors form higher order oligomers at physiological expression levels
W Guo, E Urizar, M Kralikova, JC Mobarec, L Shi, M Filizola, JA Javitch
The EMBO journal 27 (17), 2293-2304, 2008
3782008
[3H] mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
JA Javitch, RO Blaustein, SH Snyder
Molecular Pharmacology 26 (1), 35-44, 1984
3681984
Uptake of MPP (+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP
JA Javitch
Eur. J. Pharmacol. 106, 455-456, 1984
3651984
The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer
W Guo, L Shi, JA Javitch
Journal of Biological Chemistry 278 (7), 4385-4388, 2003
3452003
系统目前无法执行此操作,请稍后再试。
文章 1–20